---
title: CAR-T Therapy for Refractory Thyroid Cancer Receives IND Approval
description: CAR-T Therapy for Refractory Thyroid Cancer Receives IND Approval
---

[News ](https://www.yourway.com/news)

# [CAR-T Therapy for Refractory Thyroid Cancer Receives IND Approval](https://www.yourway.com/news/car-t-therapy-for-refractory-thyroid-cancer-receives-ind-approval-1)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | November 8, 2019

AffyImmune Therapeutics announced [FDA approval ](https://www.prnewswire.com/news-releases/affyimmune-therapeutics-announces-ind-approval-for-a-first-in-man-trial-of-affinity-tuned-car-t-cells-for-patients-with-advanced-refractory-thyroid-cancer-300948315.html)of their investigational new drug (IND) for AIC100, a CAR-T cell therapy aimed at treating patients with advanced thyroid cancer. The first-in-human phase I study will be sponsored by Weill Cornell Medical Center. Yourway is anticipating a surge in clinical trials exploring these advanced therapies, and is prepared to support any customers for their unique needs.

[View full post](https://www.yourway.com/news/car-t-therapy-for-refractory-thyroid-cancer-receives-ind-approval-1)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2019-11-08T10:00:00.458Z",
  "datePublished" : "2019-11-08T10:00:00Z",
  "headline" : "CAR-T Therapy for Refractory Thyroid Cancer Receives IND Approval",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1413,
    "url" : "https://cdn2.hubspot.net/hubfs/5402331/News%20and%20Articles%20Banners/new_november/iStock-618440436.jpg",
    "width" : 2123
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/car-t-therapy-for-refractory-thyroid-cancer-receives-ind-approval-1",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```